Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 50228-424

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 50228-424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Ranolazine, 1000mg Bottle, 30ct (Ranolazine 1000mg 30tab)

This is a description of a medication called Ranolazine. It is an extended-release tablet that contains 1,000 mg of the medication. The tablets should be stored at a temperature between 15°C to 30°C (59°F to 86°F). The usual dosage is not given and should be checked from the package insert. These tablets are manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY 11788. They come in a bottle of 30 tablets and should be swallowed whole, not crushed, broken, or chewed. The medication is only available with a prescription (Rx only). The description doesn't contain non-English characters.*

FDA Label Image

Package Label – Ranolazine, 1000mg Bottle, 500ct (Ranolazine 1000mg 500tab)

Each tablet of Ranolazine contains 1,000mg of the medication. It must be stored between 15°C and 25°C. The package insert should be consulted for appropriate dosage and administration instructions. The tablets are manufactured by Sceben Pharmaceuticals, based in Hauppauge, NY, and come in a bottle of 500 tablets. The medication is extended-release, and the tablets must be swallowed whole; they should not be crushed, broken, or chewed. The NDC is 50228-424-05, and it is available by prescription only.*

FDA Label Image

Package Label – Ranolazine, 1000mg Bottle, 60ct (Ranolazine 1000mg 60tab)

This is a description for a medication called Ranolazine Extended-Release. The tablet contains 1000 mg of the medicine, and it is advised to store it at 25°C (77°F). The usual dosage information can be found inside the package insert. The tablets should be swallowed whole and not crushed, broken, or chewed. The medication is manufactured by a company called ScieGen Pharmaceuticals. This description might be useful for people who are looking for information about Ranolazine Extended-Release medication.*

FDA Label Image

Package Label – Ranolazine, 500mg Bottle, 30ct (Ranolazine 500mg 30tab)

Each tablet of Ranolazine contains 500mg of the medicine. The tablets should be stored in a controlled temperature between 15 to 30 degrees Celsius. The medication should be ingested whole and should not be crushed or chewed. The usual dosage for the medication can be found in the package insert. The medication is manufactured by ScieGen Pharmaceuticals, Inc. and comes in a bottle containing 30 tablets. No other information is available due to lack of clarity of some characters obtained by .*

FDA Label Image

Package Label – Ranolazine, 500mg Bottle, 500ct (Ranolazine 500mg 500tab)

Each tablet of Ranolazine Extended-Release contains 500 mg of Ranolazine. The recommended storage temperature is between 15°C to 30°C (63°F to 86°F) with permitted excursions. Dosage and administration instructions are provided in the package insert. These tablets are manufactured by Sciegen Pharmaceuticals in Hauppauge, NY and are available in a bottle packaging of 500 tablets. It is recommended to swallow the tablet whole and not to break, crush, or chew. This product is only available on prescription.*

FDA Label Image

Package Label – Ranolazine, 500mg Bottle, 60ct (Ranolazine 500mg 60tab)

Each tablet of this medication contains 500 mg of Ranolazine, identified by NDG 50228-423-60. The medication is called Sovatzse T Ranolazine and is an extended-release medication. It should be stored at room temperature between 10-15°C (59°F - 86°F). The packaging should be checked for instructions on dosage and administration, and the tablets themselves should be swallowed whole, not chewed or crushed. The manufacturer is ScieGen Pharmaceuticals, located in Hauppauge, NY.*

FDA Label Image

Chemical Structure (Ranolazine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.